Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Phosphagenics Limited

Market Cap 42.13M 29.72M 25.67M 23.65M 22.14M 41.49M 2.82B 279M 109M 1.37B 112M 109M 4.76B P/E Ratio 2024
-2.5x
P/E Ratio 2025 -6.43x
Enterprise Value 37.49M 26.44M 22.84M 21.04M 19.7M 36.91M 2.51B 248M 96.88M 1.22B 99.23M 97.11M 4.24B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
75.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2020-04-30
Chief Operating Officer - 2020-04-30
Corporate Secretary - 2026-04-30
Director TitleAgeSince
Director/Board Member - 2015-04-12
Chairman - 2018-12-31
Director/Board Member 59 2024-04-25
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 29.72M
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
Average -1.22%+0.84%+18.93%+45.39% 380.99B
Weighted average by Cap. -0.23%+1.04%+27.77%+70.54%

Financials

2024 2025
Net sales 1.13M 799K 690K 636K 595K 1.12M 75.94M 7.51M 2.93M 36.96M 3M 2.93M 128M 1.24M 873K 754K 695K 650K 1.22M 82.98M 8.2M 3.2M 40.39M 3.28M 3.21M 140M
Net income -3.12M -2.2M -1.9M -1.75M -1.64M -3.07M -209M -20.69M -8.07M -102M -8.26M -8.09M -353M -4.42M -3.12M -2.69M -2.48M -2.32M -4.35M -296M -29.28M -11.41M -144M -11.69M -11.44M -499M
Net Debt -1.3M -915K -791K -729K -682K -1.28M -87.01M -8.6M -3.35M -42.35M -3.44M -3.36M -147M -4.65M -3.28M -2.83M -2.61M -2.44M -4.58M -312M -30.82M -12.01M -152M -12.31M -12.04M -525M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!